The team behind the World Without Disease Accelerator, part of Janssen Research & Development, one of the Janssen Pharmaceutical companies of Johnson & Johnson, is embracing an ambitious paradigm focused on disease prevention, interception and cure.
The conference highlights the intersections of technology and life sciences through the prism of precision medicine. The topics at the conference span pediatric innovation, how tech companies are addressing clinical trial challenges, supply chain management, and more.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company won the health IT track for the MedCity INVEST Pitch Perfect competition earlier this month and was one of five winners from the contest.
With the Series B, the business added two new investors to its latest funding round — AI Life Sciences Investments LLC, which is affiliated with Access Industries, and 7wire Ventures.
Many digital health and medtech entrepreneurs making better choices of which healthcare pain points to pursue.
Xact Medical will begin preclinical trials this year and hopes to get its device into procedure rooms by 2019.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Personal health records for schools and brain stimulation are among the technologies that will be showcased at the SXSW event.
It said the new capital will be used to extend its services in the Dallas/Fort Worth and Houston markets, enter the Austin market, as well as expand beyond the borders of its home state.
The Texas digital health company so far has established a customer base in Dallas and plans to add Houston next month ahead of a national expansion in September.
The collaboration with Impact Pediatric pitching event at SXSW is Sesame Ventures' first announced healthcare collaboration.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Pediatric device developer Lully , which has made preventing night terrors its focus, has added a 24 hour support service and other components in the latest version of the device. Lully’s flagship device Sleep Guardian is shaped like a hockey puck that goes under the mattress and uses a vibration-based technology to help children stay in […]
The application deadline for Impact Pediatric pitch is February 5.
ZOLL Medical Corp's LifeVest is approved for children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.
"We are not trying to replace the physician, we are trying to facilitate delivery of care," said Andrew Burns, the CEO.
PoopMD, developed at Johns Hopkins Children's Center with HCB Health, is designed to provide an easy way for parents to monitor their infant's stool color and flag up problems earlier.